1. Contractors
  2. Venatorx Pharmaceuticals Inc

Venatorx Pharmaceuticals Inc

Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)

Venatorx Pharmaceuticals has 4 federal contracts of $100,000 or more active since October 2023, with $241M obligated, from 3 agencies. 1 is still running.

Contracts
4 since FY2024$241,488,940 obligated, contracts of $100,000 or more
Running now
1 contract1 ended in the last 12 months
Biggest customer
Office of Assistant Secretary for Preparedness and Response$179M on 2 contracts
UEI
MBBKNBU5DCC6Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
Venatorx Pharmaceuticals: Antibiotic for Amr and Biothreat PathogensOffice of Assistant Secretary for Preparedness and Response · 75A50122C00080$72,141,707Dec 31, 2028in 25 monthsPA

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount, $M
Office of Assistant Secretary for Preparedness and Response2 contracts178.7
National Institutes of Health1 contract48.5
Defense Threat Reduction Agency1 contract14.3

What they sell

IndustryAmount, $M
Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 2 contracts178.7
Research and Development in BiotechnologyNAICS 541711 · 2 contracts62.8

Where the work is

Place of workAmount, $M
Pennsylvania4 contracts241.5

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Office of Assistant Secretary for Preparedness and Response: see the list.

Get new notices like Venatorx Pharmaceuticals's work

New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy